Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer
STORNIOLO, Anna Maria, PEGRAM, Mark D, PANDITE, Lini, FLEMING, Ronald A, LEBOWITZ, Peter F, HO, Peter T. C, BURRIS, Howard A, OVERMOYER, Beth, SILVERMAN, Paula, PEACOCK, Nancy W, JONES, Suzanne F, LOFTISS, Jill, ARYA, Nikita, KOCH, Kevin M, PAUL, Elaine
Published in Journal of clinical oncology (10.07.2008)
Published in Journal of clinical oncology (10.07.2008)
Get full text
Journal Article
Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study
Gilmore, James W, Peacock, Nancy W, Gu, Anna, Szabo, Stephen, Rammage, Melissa, Sharpe, Joyce, Haislip, Sally T, Perry, Toni, Boozan, Tim L, Meador, Katherine, Cao, Xiting, Burke, Thomas A
Published in Journal of oncology practice (01.01.2014)
Published in Journal of oncology practice (01.01.2014)
Get full text
Journal Article
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute
Yardley, Denise A., Bosserman, Linda D., O’Shaughnessy, Joyce A., Harwin, William N., Morgan, Susan K., Priego, Victor M., Peacock, Nancy W., Bass, J. David, Burris III, Howard A., Hainsworth, John D.
Published in Breast cancer research and treatment (01.11.2015)
Published in Breast cancer research and treatment (01.11.2015)
Get full text
Journal Article
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer
Yardley, Denise A., Shipley, Dianna L., Peacock, Nancy W., Shastry, Mythili, Midha, Rajiv, Priego, Victor M., Hainsworth, John D.
Published in Breast cancer research and treatment (01.08.2015)
Published in Breast cancer research and treatment (01.08.2015)
Get full text
Journal Article
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score
Yardley, Denise A., Peacock, Nancy W., Shastry, Mythili, Burris, Howard A., Bechhold, Rebecca G., Hendricks, Carolyn B., Yoshizawa, Carl N., Sing, Amy P., Hainsworth, John D.
Published in Breast cancer research and treatment (01.11.2015)
Published in Breast cancer research and treatment (01.11.2015)
Get full text
Journal Article
Patient Perspectives on Breast Cancer Treatment Plan and Summary Documents in Community Oncology Care: A Pilot Program
BLINDER, Victoria S, NORRIS, Virginia W, PEACOCK, Nancy W, GRIGGS, Jennifer J, HARRINGTON, David P, MOORE, Anne, THERIAULT, Richard L, PARTRIDGE, Ann H
Published in Cancer (2013)
Published in Cancer (2013)
Get full text
Journal Article
Phase 1 Results From a Study of Romidepsin in Combination With Gemcitabine in Patients With Advanced Solid Tumors
Jones, Suzanne F., Infante, Jeffrey R., Spigel, David R., Peacock, Nancy W., Thompson, Dana S., Greco, F. Anthony, McCulloch, William, Burris III, Howard A.
Published in Cancer investigation (01.07.2012)
Published in Cancer investigation (01.07.2012)
Get full text
Journal Article
A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer
Yardley, Denise A, Peacock, Nancy W, Dickson, Natalie R, White, Melissa B, Vázquez, Elizabeth R, Foust, John T, Grapski, Richard, Hendricks, Linda K, Scott, William L, Hainsworth, John D
Published in Clinical breast cancer (01.06.2010)
Published in Clinical breast cancer (01.06.2010)
Get full text
Journal Article
A Phase II Feasibility Trial of Dose-Dense Docetaxel Followed by Doxorubicin/Cyclophosphamide as Adjuvant or Neoadjuvant Treatment for Women with Node-Positive or High-Risk Node-Negative Breast Cancer
Yardley, Denise A, Burris, Howard A, Farley, Cindy P, Barton, John H, Peacock, Nancy W, Spigel, David R, Greco, F. Anthony, Hainsworth, John D
Published in Clinical breast cancer (01.06.2008)
Published in Clinical breast cancer (01.06.2008)
Get full text
Journal Article
Abstract PS11-29: A phase 2 study evaluating orteronel, an inhibitor of androgen biosynthesis, in patients with androgen receptor (AR)-expressing metastatic triple-negative breast cancer (TNBC)
Yardley, Denise A, Young, Robyn R, Adelson, Kerin B, Silber, Andrea L, Kommor, Michael D, Najera, Jose E, Daniel, Davey B, Peacock, Nancy W, Shastry, Mythili, Hainsworth, John D, Burris, Howard A
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract OT2-1-07: A phase II study with orteronel as monotherapy in patients with androgen receptor (AR) expressing metastatic breast cancer (MBC)
Yardley, Denise A, Jones, Suzanne F, Peacock, Nancy W, Shastry, Mythili, Young, Robyn R, Kallab, Andre M, Burris III, Howard A
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care
Blinder, Victoria S., Norris, Virginia W., Peacock, Nancy W., Griggs, Jennifer J., Harrington, David P., Moore, Anne, Theriault, Richard L., Partridge, Ann H.
Published in Cancer (01.01.2013)
Published in Cancer (01.01.2013)
Get full text
Journal Article
A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors
PEACOCK, N. W, BURRIS, H. A, VON HOFF, D. D, DIERAS, V, SMITH, L, RODRIGUEZ, G. I, ECKARDT, J. R, JONES, S. F, HARDY, J, HOHNEKER, J, BIGLEY, J
Published in Investigational new drugs (01.01.1998)
Published in Investigational new drugs (01.01.1998)
Get full text
Journal Article